Navigation Links
MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) RECEIVES FDA APPROVAL FOR GLUCOSE CONTROL IN ADULTS WITH TYPE 2 DIABETES MELITUS
Date:1/18/2008

Daiichi Sankyo, Inc. announced today that the United States Food and Drug Administration (FDA) has approved WelChol(R) (colesevelam HCl) Tablets as the first LDL cholesterol lowering medication also indicated for improving glycemic control in adults with type 2 diabetes mellitus (DM) in combination with metformin, sulfonylureas, or insulin, when these agents are used alone or in combination with other anti-diabetic agents.

The ADA estimates that 20.8 million people in the United States have diabetes and more than 90% of these have type 2 diabetes. People with diabetes face significantly higher risk of developing cardiovascular disease. It is estimated that approximately half of all Americans have elevated blood cholesterol levels that can negatively impact their health and quality of life. According to a recent Harris Interactive Survey, approximately 29% of adults previously diagnosed with hypercholesterolemia have also been diagnosed with diabetes. Given the prevalence of diabetes and high LDL cholesterol, a medication that can help lower both A1C and LDL cholesterol can be beneficial for many patients. Welchol is a new option that addresses these two chronic health conditions and provides physicians with a different therapeutic approach for treating patients with type 2 diabetes.
For more information, please visit http://www.dsus.com.

SATELLITE FEED:

Friday, January 18th, 2008

6:30 PM - 6:45 PM ET

Galaxy 25

C-Band

Transponder 14

Downlink Freq. 3980 Horizontal

Preview and access this video on Pathfire DMG: Slug # 29711

Search within the PR Newswire or MultiVu section by story ID # 29711 or by headline

For technical assistance call Pathfire Customer Care at 1-888-345-0489 or e-mail support@pathfire.com

NEWS: WelChol Receives FDA Approval To Reduce Blood Glucose in Adults with Type 2 Diabetes

FORMAT: B-roll and Soundbites.

ADDITIONAL RESOURCES: Video, contact information and more available at: http://www.prnewswire.com/broadcast/29711/press.html

SOUNDBITES:

* Dr. Ronald B. Goldberg, Professor of Medicine and Professor,

Biochemistry and Molecular Biology at the University of Miami and the

Associate Director of the Diabetes Research Institute

B-ROLL INCLUDES:

* Doctor/Patient footage

* Patient lifestyle & footage

* Product shots/manufacturing footage

* Daiichi Sankyo exteriors

VIDEO PROVIDED BY: Daiichi Sankyo

Contact: FOR MORE INFORMATION, PLEASE CALL: MultiVu Media Relations, 1-800-653-5313 EXT. 3


'/>"/>
SOURCE Daiichi Sankyo
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Photo: MultiVu Promotes George DeTorres to Divisional Vice President for the MultiVu Healthcare Team
2. MultiVu Video Feed: NEW SURVEY FINDS THAT HALF OF CAREGIVERS SPEND 10 PERCENT OF THEIR INCOME CARING FOR AN OLDER LOVED ONE
3. MultiVu Video Feed: STARLIGHT STARBRIGHT UNVEILS GET FIT, GET RIGHT A PROGRAM TO PREVENT TYPE 2 DIABETES AND WEIGHT-RELATED CONDITIONS IN TEENS
4. MultiVu Video Feed: Parents of Kids With Infectious Diseases Sounds Alarm About the Dangers of Pertussis With "Silence the Sounds of Pertussis" Campaign
5. MultiVu Video Feed: FDA Approves DORIBAX(TM) (doripenem for injection) for the Treatment of Complicated Intra-abdominal and Complicated Urinary Tract Infections
6. MultiVu Video Feed: PUBLIC HEALTH EXPERTS CONVENE TO DISCUSS THE TREATMENT AND PREVENTION OF RABIES
7. VIDEO from Medialink and The Leukemia & Lymphoma Society: Saving Lives One Mile at a Time
8. VIDEO from Medialink and Stryker: New Alternative to Hip Replacement Surgery
9. InfoLogix Featured in FOX Business News Interview on Reducing Healthcare Medication Errors - Video Available Online
10. VIDEO from Medialink and Revolution Health: RevolutionHealth.com Launches Resolutions 2.0
11. VIDEO from Medialink and GlaxoSmithKline: Really Think You Can Lose 30 Pounds in 30 Days?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
(Date:6/24/2016)... TX (PRWEB) , ... June 24, 2016 , ... People ... part in Genome magazine’s Code Talker Award, an essay contest in which patients and ... an award to be presented at the 2016 National Society of Genetic Counselors (NSGC) ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: